Chonghui Li

Chonghui Li


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 January 2020 in Journal of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
HCHuayong Cai
Huayong Cai
YZYu Zhang
Yu Zhang
HZHaoyun Zhang
Haoyun Zhang
CCChao Cui
Chao Cui
CLChonghui Li
Chonghui Li
SLShichun Lu
Shichun Lu

1 March 2017 in Microvascular Research
Verified
Journal Article
Closed access
CLChonghui Li
Chonghui Li
XGXin Lan Ge
Xin Lan Ge
KPKe Pan
Ke Pan
PWPeng Fei Wang
Peng Fei Wang
YSYi Nan Su
Yi Nan Su
AZAi Qun Zhang
Ai Qun Zhang

6 February 2023 in Frontiers in Immunology
Verified
Journal Article
Open access
BGBiao Gao
Biao Gao
YWYafei Wang
Yafei Wang
CLChonghui Li
Chonghui Li
SLShichun Lu
Shichun Lu
Background: Immunotherapy has been the first-line treatment option in advanced Hepatocellular Carcinoma(HCC); but now, there are no established molecular markers that can predict immunotherapy response. Estrogen has a crucial role in the development of a variety of liver illnesses, including liver fibrosis, Nonalcoholic fatty liver disease (NAFLD), and HCC. Nonetheless, the significance of estrogen-related genes in HCC immunotherapy and the underlying molecular mechanisms are not yet fully understood.Method: In this study, we constructed a novel estrogen-related gene prognostic signature (ERGPS) by analyzing bulk RNA sequencing data from 365 HCC patients. Based on the median risk score, we divided 365 HCC patients into low- and high-risk groups. Tumor mutation burden (TMB), Microsatellite instability (MSI), T cell receptor (TCR) richness, B cell receptor (BCR) richness, single-nucleotide variants (SNV) Neoantigens, Cancer Testicular Antigens (CTA) scores, and Tumour Immune Dysfunction and Exclusion (TIDE) scores were used to evaluate the magnitude of immunotherapy response. Multiple external datasets validate the validity and robustness of the prognostic signature. Real-time quantitative polymerase chain reaction (qRT-PCR) was used to validate estrogen-related gene overexpression in HCC tissue samples.Results: ERGPS is an independent risk factor affecting the prognosis of HCC patients and is superior to other clinical variables in predicting patient survival and immunotherapy response. Multiple independent external datasets confirmed the superior predictive efficacy of the prognostic signature. The prognostic signature was positively correlated with TMB score, MSI score, TCR richness, BCR richness, SNV Neoantigens score, CTA score, expression levels of immune checkpoint-related genes, and TIDE score. Patients with HCC in the high-risk group identified by the prognostic signature were likely to be more responsive to immunotherapy and more suitable for immunotherapy. qRT-PCR confirmed that estrogen-related genes of the construct signature were highly expressed in HCC tumor tissues.Conclusion: Estrogen-related genes are overexpressed in HCC tissues. Our novel prognostic signature can accurately predict not only the prognosis but also the immunotherapy response of HCC patients. In the future, prognostic signatures will be a useful tool for clinicians to screen patients with HCC who are suitable for immunotherapy.

8 September 2019 in Medical Science Monitor
Verified
Journal Article
Closed access
PDF file
HLHao Li
Hao Li
XGXinlan Ge
Xinlan Ge
KPKe Pan
Ke Pan
MSMinghao Sui
Minghao Sui
HCHuayong Cai
Huayong Cai
SLShichun Lu
Shichun Lu
BACKGROUND:Matricellular proteins of the extracellular matrix (ECM) include tenascin-C (TNC) and cellular communication network factor 3 (CCN3). This study aimed to investigate the role of TNC and CCN3 as prognostic factors for post hepatectomy liver...

2 November 2022 in Experimental and Therapeutic Medicine
Verified
Journal Article
Open access
PDF file
XGXinlan Ge
Xinlan Ge
DXDabin Xu
Dabin Xu
KPKe Pan
Ke Pan
GMGuankun Mao
Guankun Mao
SLShichun Lu
Shichun Lu
CLChonghui Li
Chonghui Li
Due to the lack of a suitable model, research on biliary biology is far behind that on other organs. A mouse model of common bile duct (CBD) dilation (BDD) was first established and compared with CBD ligation mice (BDL). Then, in a transplantation experiment, the dilated CBD of recipient BDD mice was injured by making an elliptical incision and repaired by transplanting a bile duct patch from donor BDD mice. Biochemical and histological changes were analyzed and cell proliferation of the bile duct grafts was determined. Slightly dilated and unblocked CBD with a diameter of 2.89±0.76 mm was obtained in BDD mice, while the CBD diameter was 0.51±0.08 mm in the Sham group and 4.71±0.64 mm in the BDL group on day 14 after surgery. The liver damage was very mild in BDD mice compared with BDL mice, proving that the BDD model could be further used for bile duct transplantation. By cross transplanting the bile duct patch from enhanced green fluorescence protein and wild‑type BDD mice, it was found that the CBD injury was well repaired and the cells of the bile duct patch were completely replaced by recipient‑derived cells at 12 week after the repair operation. α Smooth muscle actin, Ki67 and cytokeratin 19 immunofluorescence staining showed that the proliferation of bile duct epithelial cells and abundant active fibroblasts were found within the bile duct patch during the regeneration process. Therefore, a reliable new mouse model of bile duct injury and repair was successfully established and can be used in the study of biliary repair mechanisms and tissue engineering of biliary ducts.

1 January 2026 in Advanced Biomedical Research
Verified
Journal Article
Open access
XGXinlan Ge
Xinlan Ge
KPKe Pan
Ke Pan
QYQiyue Yang
Qiyue Yang
LGLijie Gao
Lijie Gao
CLChonghui Li
Chonghui Li
Background: Post-hepatectomy liver failure (PHLF) is the most serious complication after extended hepatectomy, with a high perioperative mortality rate. Matricellular protein tenascin-C (TNC) has been related to blood flow change and inflammation. We aimed to explore the hepatic changes of TNC and its relationship with PHLF. Materials and Methods: Rats were divided into seven groups: Sham operation, 90% partial hepatectomy (90PH) as a PHLF model, 85% (85PH), and 68% (68PH) hepatectomy without or with lipopolysaccharide (LPS) treatment. The distribution of TNC protein, the mRNA expression of TNC and other endothelial response genes, and the cellular TNC located in the rat livers were evaluated by immunostaining, quantitative real-time polymerase chain reaction, and RNAscope assay. Results: TNC mRNA in the liver tissue was significantly upregulated after hepatectomy and reached the highest level in the 90PH rats compared with those in the 85PH and 68PH rats. This upregulation was closely correlated with the changes of severe liver injury, inhibited liver regeneration, and upregulation of KLF2, ET-1, eNOS, and TM-1 in 90PH rat livers. We found a robust disturbance of hepatic TNC protein distribution in 90PH rat livers with an obvious reduction in hepatic sinusoids but an increase around large blood vessels, which were consistent with the severe liver injury of the 90PH rats. It was also found for the first time that treatment with the endotoxin LPS tremendously exacerbated the above changes of TNC. Conclusion: The distribution and expression of TNC mRNA changed dramatically and contributed to the occurrence of PHLF.